Suraksha Diagnostic IPO
Everything You Need to Know
Company Overview
A leading diagnostics chain with a strong presence in Eastern and Northeastern India.
About the Company
Offers
pathology
and
radiology
service
Operates
43 diagnostic centers
and over
215 touchpoint
Founded in
2005
IPO Details
Price Band:
₹420 – ₹441 per share
Face Value:
₹2 per share
Lot Size:
34 shares
Issue Type:
Offer for Sale
Key Dates to Remember
Opening Date:
November 29, 2024
Allotment Date:
December 4, 2024
Closing Date:
December 3, 2024
Listing Date:
December 6, 2024
Reservation
Retail Quota:
35%
QIB Quota:
50%
NII Quota:
15%
Financial Performance
Revenue:
₹222.26 crore
PAT Growth YoY:
281%
Profit After Tax:
₹23.13 crore
Why Invest in Suraksha Diagnostic?
Strong market position in Eastern India
Growing demand for healthcare services
Wide range of diagnostic tests (2,300+)
Risks to Consider
High dependency on Eastern India for revenue
Regulatory and operational challenges
Competition from larger diagnostic chains
Industry Outlook
The Indian diagnostics industry is projected to grow at a
CAGR of 10-12%
, driven by:
Expansion into Tier 2 and Tier 3 cities
Increased healthcare awareness
Rising demand for preventive care
Final Thoughts
Suraksha Diagnostic IPO offers investors a chance to enter the expanding healthcare diagnostics sector with a regional leader.
Swipe up to know more about the Suraksha Diagnostic IPO.
Learn more